Nanoparticle-based drug may soon be launched in healthcare industry
Date: 2018-03-06   Author: Pankaj Singh  Category: #industry

Nanoparticle-based drug may soon be launched in healthcare industry

Acclaimed scientists from the Russian ITMO University may soon revolutionize healthcare and medical devices industry with their latest discovery. As per reliable sources, they have discovered that magnetically-driven nanoparticles containing thrombin are rather effective to stop internal bleeding. A drug based on these nanoparticles, if and when conceived, can apparently be directly delivered to the vascular injury site.

Apparently, these nanoparticles are not hazardous for human beings and can be used for safe diagnosis. They improve clot formation and curb overall blood loss by fifteen times, proving to be rather beneficial for internal bleeding.

Though there are various drugs available for internal bleeding in healthcare and medical devices industry, none of them have proven effective without surgical intervention. The only possible solution, claim scientists, is to develop a rather quick and effective treatment. In this regard, scientists had commenced the development of drugs that may be provided through a simple injection. A constraint with this medication therapy is that the clot formation has to be initiated only at vessel damage without affecting the entire vascular system. ITMO’s latest research, claim reports, seems to be in alignment with this school of thought regarding internal bleeding.

As per research, thrombin enzyme and mineral are the two vital components in magnetically-driven nanoparticles. Thrombin enzyme interacts with fibrinogen protein and leads to clot formation, blocking the damaged vessel. The other important ingredient, the mineral, allows particles to move inside the body with the help of an external magnetic field.

ITMO’s laboratory head, Vladimir Vinogrado, has been quoted stating that synthesizing these nanoparticles had not been easy. It had been vital to keep their size below 200 nanometers without which they would have been deemed unsuitable for an injection. He further added that even the toxicity of the particles with human cells had been tested, post which it was found that these particles are completely safe even with long-lasting exposure.

In the event that this drug is commercially available, it is certain to transform healthcare and medical devices industry outlook, say experts.



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Gynecological Device Market Size Outlook 2025: Top Companies, Trends, Growth Factors Details by Regions, Types and Applications
Author: Partha Ray

This report Added by Market Study Report, LLC, focuses on factors influencing the present scenario of the ' Gynecological Device market'. The research report also offers concise analysis referring to commercialization aspects, profit estimation an...


GPRS Mobile Phone Market Size 2025 - Industry Sales, Revenue, Price and Gross Margin, Import and Export Status
Author: Partha Ray

The ' GPRS Mobile Phone market' research added by Market Study Report, LLC, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercializa...


Freewheels Market Size : Technological Advancement and Growth Analysis with Forecast to 2025
Author: Partha Ray

The ' Freewheels market' research report added by Market Study Report, LLC, is a thorough analysis of the latest trends prevalent in this business. The report also dispenses valuable statistics about market size, participant share, and consumption...